Hunan Er Kang Pharmaceutical (300267) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.034x

Based on the latest financial reports, Hunan Er Kang Pharmaceutical (300267) has a cash flow conversion efficiency ratio of 0.034x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥174.55 Million ≈ $25.54 Million USD) by net assets (CN¥5.09 Billion ≈ $745.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hunan Er Kang Pharmaceutical - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Hunan Er Kang Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Hunan Er Kang Pharmaceutical carry for a breakdown of total debt and financial obligations.

Hunan Er Kang Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Er Kang Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Insigma SHG:600797	0.029x
Beijing Urban Rural Commercial Group Co Ltd SHG:600861	0.061x
Suzhou Oriental Semiconductor Co. Ltd. A SHG:688261	-0.008x
Orange Belgium SA BR:OBEL	0.130x
Milkyway Chemical Supply Chain Service Co Ltd SHG:603713	-0.059x
Ladder Capital Corp Class A NYSE:LADR	0.031x
HBM Healthcare Investments SW:HBMN	0.000x
Ye Chiu Metal Recycling China Ltd SHG:601388	-0.026x

Annual Cash Flow Conversion Efficiency for Hunan Er Kang Pharmaceutical (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Er Kang Pharmaceutical from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Hunan Er Kang Pharmaceutical market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.40 Billion ≈ $644.18 Million	CN¥166.69 Million ≈ $24.39 Million	0.038x	+22.71%
2023-12-31	CN¥4.81 Billion ≈ $703.86 Million	CN¥148.42 Million ≈ $21.72 Million	0.031x	-44.54%
2022-12-31	CN¥5.05 Billion ≈ $739.13 Million	CN¥281.02 Million ≈ $41.12 Million	0.056x	+192.56%
2021-12-31	CN¥4.87 Billion ≈ $713.18 Million	CN¥92.68 Million ≈ $13.56 Million	0.019x	-38.29%
2020-12-31	CN¥5.79 Billion ≈ $847.78 Million	CN¥178.53 Million ≈ $26.12 Million	0.031x	-59.96%
2019-12-31	CN¥5.79 Billion ≈ $847.71 Million	CN¥445.82 Million ≈ $65.24 Million	0.077x	+250.28%
2018-12-31	CN¥5.64 Billion ≈ $825.21 Million	CN¥123.89 Million ≈ $18.13 Million	0.022x	-82.75%
2017-12-31	CN¥5.41 Billion ≈ $791.90 Million	CN¥689.11 Million ≈ $100.84 Million	0.127x	+37.27%
2016-12-31	CN¥5.24 Billion ≈ $767.41 Million	CN¥486.50 Million ≈ $71.19 Million	0.093x	-23.90%
2015-12-31	CN¥4.26 Billion ≈ $622.97 Million	CN¥518.96 Million ≈ $75.94 Million	0.122x	+16.62%
2014-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥175.38 Million ≈ $25.66 Million	0.105x	-19.97%
2013-12-31	CN¥1.33 Billion ≈ $195.21 Million	CN¥174.22 Million ≈ $25.49 Million	0.131x	+80.97%
2012-12-31	CN¥1.16 Billion ≈ $170.37 Million	CN¥84.02 Million ≈ $12.30 Million	0.072x	+1.24%
2011-12-31	CN¥1.06 Billion ≈ $155.44 Million	CN¥75.72 Million ≈ $11.08 Million	0.071x	-70.36%
2010-12-31	CN¥176.62 Million ≈ $25.85 Million	CN¥42.47 Million ≈ $6.21 Million	0.240x	+159.86%
2009-12-31	CN¥110.01 Million ≈ $16.10 Million	CN¥10.18 Million ≈ $1.49 Million	0.093x	+2663.24%
2008-12-31	CN¥63.01 Million ≈ $9.22 Million	CN¥211.00K ≈ $30.88K	0.003x	--

About Hunan Er Kang Pharmaceutical

SHE:300267 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.32 Billion

CN¥8.99 Billion CNY

Market Cap Rank

#7929 Global

#1981 in China

Share Price

CN¥4.36

Change (1 day)

+3.81%

52-Week Range

CN¥2.93 - CN¥4.69

All Time High

CN¥17.60